Your browser doesn't support javascript.
loading
Enhanced antitumor immunity by a novel small molecule HPK1 inhibitor.
You, Dan; Hillerman, Stephen; Locke, Gregory; Chaudhry, Charu; Stromko, Caitlyn; Murtaza, Anwar; Fan, Yi; Koenitzer, Jennifer; Chen, Yali; Briceno, Stephanie; Bhadra, Rajarshi; Duperret, Elizabeth; Gullo-Brown, Johnni; Gao, Chan; Zhao, Dandan; Feder, John; Curtin, Joshua; Degnan, Andrew P; Kumi, Godwin; Wittman, Mark; Johnson, Benjamin M; Parrish, Karen E; Gokulrangan, Giridharan; Morrison, John; Quigley, Michael; Hunt, John T; Salter-Cid, Luisa; Lees, Emma; Sanjuan, Miguel A; Liu, Jinqi.
Affiliation
  • You D; Oncology Discovery, Bristol-Myers Squibb Co, Princeton, New Jersey, USA.
  • Hillerman S; Oncology Discovery, Bristol-Myers Squibb Co, Princeton, New Jersey, USA.
  • Locke G; Oncology Discovery, Bristol-Myers Squibb Co, Princeton, New Jersey, USA.
  • Chaudhry C; Oncology Discovery, Johnson and Johnson Limited, Spring House, Pennsylvania, USA.
  • Stromko C; Oncology Discovery, Bristol-Myers Squibb Co, Princeton, New Jersey, USA.
  • Murtaza A; Oncology Discovery, Bristol-Myers Squibb Co, Princeton, New Jersey, USA.
  • Fan Y; Oncology Discovery, Bristol-Myers Squibb Co, Princeton, New Jersey, USA.
  • Koenitzer J; Oncology Discovery, Bristol-Myers Squibb Co, Princeton, New Jersey, USA.
  • Chen Y; Oncology Discovery, Bristol-Myers Squibb Co, Princeton, New Jersey, USA.
  • Briceno S; Oncology Discovery, Bristol-Myers Squibb Co, Princeton, New Jersey, USA.
  • Bhadra R; Oncology Discovery, Pfizer Inc, San Diego, California, USA.
  • Duperret E; Oncology Discovery, Bristol-Myers Squibb Co, Princeton, New Jersey, USA.
  • Gullo-Brown J; Oncology Discovery, Pfizer Inc, San Diego, California, USA.
  • Gao C; Oncology Discovery, Bristol-Myers Squibb Co, Princeton, New Jersey, USA.
  • Zhao D; Oncology Discovery, Bristol-Myers Squibb Co, Princeton, New Jersey, USA.
  • Feder J; Oncology Discovery, Bristol-Myers Squibb Co, Princeton, New Jersey, USA.
  • Curtin J; Oncology Discovery, Johnson and Johnson Limited, Spring House, Pennsylvania, USA.
  • Degnan AP; Oncology Discovery, Bristol-Myers Squibb Co, Princeton, New Jersey, USA.
  • Kumi G; Oncology Discovery, Bristol-Myers Squibb Co, Princeton, New Jersey, USA.
  • Wittman M; Oncology Discovery, Bristol-Myers Squibb Co, Cambridge, Massachusetts, USA.
  • Johnson BM; Oncology Discovery, Bristol-Myers Squibb Co, Cambridge, Massachusetts, USA.
  • Parrish KE; Oncology Discovery, Bristol-Myers Squibb Co, Princeton, New Jersey, USA.
  • Gokulrangan G; Oncology Discovery, Bristol-Myers Squibb Co, Princeton, New Jersey, USA.
  • Morrison J; Oncology Discovery, Bristol-Myers Squibb Co, Princeton, New Jersey, USA.
  • Quigley M; Oncology Discovery, Gilead Sciences Inc, Foster City, California, USA.
  • Hunt JT; Oncology Discovery, Bristol-Myers Squibb Co, Princeton, New Jersey, USA.
  • Salter-Cid L; Oncology Discovery, Gossamer Bio, San Diego, California, USA.
  • Lees E; Oncology Discovery, Bristol-Myers Squibb Co, Cambridge, Massachusetts, USA.
  • Sanjuan MA; Oncology Discovery, Bristol-Myers Squibb Co, Princeton, New Jersey, USA.
  • Liu J; Oncology Discovery, Bristol-Myers Squibb Co, Princeton, New Jersey, USA jinqi.liu@bms.com.
J Immunother Cancer ; 9(1)2021 01.
Article in En | MEDLINE | ID: mdl-33408094
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Sarcoma / Bone Neoplasms / Protein Serine-Threonine Kinases / Ginsenosides / Antineoplastic Agents Limits: Animals / Humans Language: En Journal: J Immunother Cancer Year: 2021 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Sarcoma / Bone Neoplasms / Protein Serine-Threonine Kinases / Ginsenosides / Antineoplastic Agents Limits: Animals / Humans Language: En Journal: J Immunother Cancer Year: 2021 Document type: Article